Insulin-like growth factor-I enhances transforming growth factor-β-induced extracellular matrix protein production through the p38/activating transcription factor-2 signaling pathway in keloid fibroblasts

Journal of Investigative Dermatology

Volumn 120, Issue 6, 2003, Pages 956-962

  Daian, Takehiro ^a   Ohtsuru, Akira ^a   Rogounovitch, Tatiana ^a   Ishihara, Hiroshi ^a   Hirano, Akiyoshi ^a   Akiyama Uchida, Yuri ^a   Saenko, Vladimir ^a   Fujii, Tohru ^a   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Collagen type I; Fibronectin; Fibrosis; Mitogen activated protein kinase; Plasminogen activator inhibitor 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN TYPE 1; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WORTMANNIN;

ADULT; AGED; ARTICLE; CASE REPORT; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0038129604     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12143.x     Document Type: Article

References (33)

1. Akiyama-Uchida Y, Ashizawa N, Ohtsuru A, et al: Norepinephrine enhances fibrosis mediated by TGF-β in cardiac fibroblasts. Hypertension 40:148-154, 2002
2. Babu M, Diegelmann RF, Oliver N: Keloid fibroblasts exhibit an altered response to TGF-β J Invest Dermatol 99:650-655, 1992
3. Backer JM, Myers MG, Shoelson SE, et al: Phosphatidylinositol 3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479, 1992
4. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
5. Chin GS, Liu W, Peled Z, et al: Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108:423-429, 2001
6. Chodon T, Sugihara T, Igawa HH, et al: Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157:1661-1669, 2000
7. Dennler S, Itoh S, Vivien D, Dijke Part Huet S, Gauthier JM: Direct binding of Smad3 and Smad4 to critical TGF-β -inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100, 1998
8. Derynek R, Zhang Y, Feng XH: Smad: Transcriptional activators of TGF-β responses. Cell 95:737-740, 1998
9. Finlay GA, Thannickal VJ, Fanburg BL, et al: Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 275:27650-27656, 2000
10. Frey RS, Mulder KM: Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 57:628-633, 1997
11. Ghahary A, Tredget EE, Shen Q, et al: Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Growth Factors 17:167-176, 2000
12. Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 267:389-393, 1995
13. Hanafusa HE, Ninomiya TJ, Masuyama N, et al: Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274:27161-27167, 1999
14. Heldin CH, Miyazono K, Dijke P: TGF-β signaling from cell membrane to nucleus through Smad proteins. Nature 390:465-471, 1997
15. Huang HC, Murtaugh LC, Vizw PD, Whitman M: Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo. EMBO J 14:5965-5973, 1995
16. Ishihara H, Yoshimoto H, Fujioka M, et al: Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 115:1065-1071, 2000
17. Kara CJ, Liou HC, Ivashkiv LB, Glimcher LH: A cDNA for a human cyclic AMP response element-binding protein is distinct from CREB and expressed preferentially in brain. Mol Cell Biol 10:1347-1357, 1990
18. Ohtsuru A, Yoshimoto H, Ishihara H, et al: Insulin-like growth factor-I (IGF-I)/IGF-I receptor axis and increased invasion activity of fibroblasts in keloid. Endocr J 47 (Suppl.):S41-S44, 2000
19. Pena TL, Chen SH, Konieczny SF, Rane SG: Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J Biol Chem 275 (18):13677-13682, 2000
20. Ravanti L, Toriseva M, Penttinen R, et al: Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase. FASEB J 15:1098-1100, 2001
21. Roberts AB, Piek E, Bottinger EP, et al: Is Stand3 a major player in signal transduction pathways leading to fibrogenesis? Chest 120 (Suppl. 1):43S-47S, 2001
22. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, et al: Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res 62:7031-7041, 2002
23. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D: The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363:83-85, 1993
24. Sato M, Shegogue D, Gore EA, et al: Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol 118:704-711, 2002
25. Skolnik EY, Lee CH, Batzer A, et al: The SH2/SH3 domain-containing protein GRB2 interacts with IRS1 and Shc: implications for insulin control of Ras-signaling. EMBO J 12:1929-1936, 1993
26. Tuan TL, Nichter LS: The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24, 1998
27. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990
28. Verrecchia F, Mauviel A: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211-215, 2002
29. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF: Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol 17:7019-7028, 1997
30. Yoshimoto H, Ishihara H, Ohtsuru A, et al: Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154:883-889, 1999
31. Younai S, Nichter LS, Wellisz T, et al: Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 33:148-151, 1994
32. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzlwe KW, Vogelstein B, Kern SE: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617, 1998
33. Zhou S, Zawel L, Lengauer C, Kinzler KW, Vogelstein B: Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol Cell 2:121-127, 1998